Cargando…
In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
The development of endocrine resistance is a common reason for the failure of endocrine therapies in hormone receptor-positive breast cancer. This review provides an overview of the different types of in vitro models that have been developed as tools for studying endocrine resistance. In vitro model...
Autores principales: | Cheng, Gary J., Leung, Euphemia Y., Singleton, Dean C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400723/ https://www.ncbi.nlm.nih.gov/pubmed/36045910 http://dx.doi.org/10.37349/etat.2022.00084 |
Ejemplares similares
-
Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer
por: Singleton, Dean C., et al.
Publicado: (2020) -
Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
por: Johnston, Simon J., et al.
Publicado: (2018) -
Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
por: Szostakowska, Małgorzata, et al.
Publicado: (2018) -
Endocrine Therapy of Estrogen Receptor-Positive Breast Cancer Cells: Early Differential Effects on Stem Cell Markers
por: Leung, Euphemia Y., et al.
Publicado: (2017) -
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
por: García-Becerra, Rocío, et al.
Publicado: (2012)